Translational Drug Development Revenue, Growth & Competitor Profile

DBA TD2

Company Profile & Annual Report for Translational Drug Development

Access the complete profile.

Translational Drug Development Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	621511 Medical Laboratories
Additional NAICS Codes	541513 Computer Facilities Management Services 5417 Scientific Research & Development Services
Address	13208 E. Shea Blvd Suite 100 Scottsdale, AZ 85259

Note: Revenues for privately held companies are statistical evaluations.


Translational Drug Development's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Translational Drug Development's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Translational Drug Development is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Translational Drug Development Annual Revenue and Growth Rate

Translational Drug Development	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Translational Drug Development's revenues are gauged from an analysis of company filings.

Translational Drug Development's Income Statement (based on Industry Averages)

Translational Drug Development P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Translational Drug Development is developing and marketing. Translational Drug Development doesn't have any recent trademark applications, indicating Translational Drug Development is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TD2 PRECISION ONCOLOGY Consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses in the field of oncology; Scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; Providing scientific research information in the field of pre-clinical testing; Pharmaceutical drug development and related services, namely, pharmaceutical products development and pharmaceutical research services	01/12/2022
TD2 - THE PRECISION ONCOLOGY CRO Consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses in the field of oncology; Scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; Providing scientific research information in the field of pre-clinical testing; Pharmaceutical drug development and related services, namely, pharmaceutical products development and pharmaceutical research services	02/20/2015
TD2 Pharmaceutical drug development services, medical and scientific research consultation services in the field of clinical trials	10/27/2003

See all trademarks and details in the Full Report.

Market Share of Translational Drug Development's Largest Competitors

A competitive analysis shows these companies are in the same general field as Translational Drug Development, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Translational Drug Development. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SDI SERVICES	Scottsdale, AZ	100
RED MOUNTAIN MED HOLDINGS	Scottsdale, AZ	60
TRANSLATIONAL DRUG DEVELOPMENT	Scottsdale, AZ	44
VALLEY OXIMETRY	Mesa, AZ	28
HEALTH WAVES	Tempe, AZ	13
IMAGING ENDPOINTS II	Scottsdale, AZ	11

Future Competition: Translational Drug Development's Fastest Growing Competitors

These companies are in the same general field as Translational Drug Development and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)